Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 31,000 TARA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 31,000 | n/a |
| Jun 13, 2025 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 24,000 | n/a |
| Jun 10, 2024 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 10,000 | n/a |
| Jun 8, 2023 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 10,000 | n/a |
| Jul 5, 2022 | Protara Therapeutics, Inc. (TARA) | Purchase | 10,000 | $31.0K |
| Jun 9, 2022 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 10,000 | n/a |
| Mar 16, 2022 | Protara Therapeutics, Inc. (TARA) | Purchase | 10,000 | $42.5K |
| Mar 14, 2022 | Protara Therapeutics, Inc. (TARA) | Purchase | 10,000 | $44.6K |
| Jun 11, 2021 | Protara Therapeutics, Inc. (TARA) | Grant/Award | 10,000 | n/a |
| Jun 8, 2021 | REGENXBIO Inc. (RGNX) | Grant/Award | 10,000 | n/a |